Biological Therapies in Inflammatory Myopathies

Biological Therapies in Inflammatory Myopathies

Idiopathic inflammatory myopathies (IIM) are a rare group of disorders that feature progressive immune-mediated skeletal muscle destruction along with skin, lung, and joint involvement. Management of IIMs necessitates glucocorticoid therapy followed by conventional steroid-sparing agents to control...

Full description

Bibliographic Details
Main Authors:	Abd El Haleem Natour, Shaye Kivity
Format:	Article
Language:	English
Published:	Rambam Health Care Campus 2023-04-01
Series:	Rambam Maimonides Medical Journal
Subjects:	abatacept bdmards idiopathic inflammatory myopathies ivig jaki rituximab
Online Access:	https://www.rmmj.org.il/issues/57/1622/manuscript

Similar Items

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
by: Alisson Pugliesi, et al.
Published: (2023-07-01)

Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis
by: Chao Zhen, et al.
Published: (2022-12-01)

Idiopathic inflammatory myopathies: Contributions from India
by: Anand Narayan Malaviya
Published: (2020-01-01)

Juvenile Idiopathic Inflammatory Myopathy at a developing Paediatric Rheumatology Clinic in Trinidad and Tobago: a case series
by: Zafir Latchan, et al.
Published: (2023-05-01)

Electrophysiological, structural, and functional disorders in patients with inflammatory cardiomyopathy secondary to inflammatory myopathy
by: Yingxian Liu, et al.
Published: (2022-07-01)

DISABILITY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
by: Natalia LOGHIN-OPREA, et al.
Published: (2019-03-01)

The Role of Exercise to Improve Physiological, Physical and Psychological Health Outcome in Idiopathic Inflammatory Myopathies (IIM)
by: Lodin K, et al.
Published: (2024-06-01)

The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies
by: Dawn M. Wahezi, et al.
Published: (2023-09-01)

Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet's Disease and Antiphospholipid Syndrome
by: Verónica Guiomar, et al.
Published: (2019-11-01)

Study on advances in the association between autoantibodies and clinical phenotypes in idiopathic inflammatory myopathy
by: ZHANG Hao, CHI Huihui, SU Yutong, YANG Chengde
Published: (2022-06-01)

Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy
by: Dourmishev Lyubomir A.
Published: (2017-03-01)

Morphological differential diagnosis of the main types of inflammatory myopathies
by: S. G. Radenska-Lopovok
Published: (2015-02-01)

Diagnostic criteria for idiopathic inflammatory myopathies. Problems of their optimization
by: O. A. Antelava, et al.
Published: (2014-09-01)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathiesResearch in context
by: Valérie Leclair, et al.
Published: (2023-10-01)

Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors
by: Decio Armanini, et al.
Published: (2021-08-01)

Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies
by: Li Qin, et al.
Published: (2021-08-01)

Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects
by: Ziqi Li, et al.
Published: (2024-11-01)

Identification of Metabolic Signature Associated with Idiopathic Inflammatory Myopathy Reveals Polyamine Pathway Alteration in Muscle Tissue
by: Jihyun Kang, et al.
Published: (2022-10-01)

Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01)

Evaluation of disease course and major complications in juvenile idiopathic inflammatory myopathy patients
by: Melike Mehveş Kaplan, et al.
Published: (2024-11-01)

What is new in idiopathic inflammatory myopathies: Mechanisms and therapies
by: Satish V Khadilkar, et al.
Published: (2020-01-01)

Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis
by: Simone Benvenuto, et al.
Published: (2021-07-01)

Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
by: Juyoung Yoo, et al.
Published: (2021-03-01)

Underdiagnosis of cardiopulmonary involvement in patients with idiopathic inflammatory myopathies
by: Aleksandra Opinc, et al.
Published: (2021-11-01)

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies
by: Joanna E. Parkes, et al.
Published: (2020-06-01)

Predictors of cardiac involvement in idiopathic inflammatory myopathies
by: Matilde Bandeira, et al.
Published: (2023-03-01)

Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population
by: Andrés Hormaza-Jaramillo, et al.
Published: (2022-08-01)

A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies
by: He Chen, et al.
Published: (2020-01-01)

A Unique Case of Myositis
by: Noa Hurvitz, et al.
Published: (2022-10-01)

Pediatric immune-mediated necrotizing myopathy
by: Chen-Hua Wang, et al.
Published: (2023-03-01)

Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes
by: Di Liu, et al.
Published: (2022-10-01)

High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
by: Christopher Nelke, et al.
Published: (2022-10-01)

Development of differential diagnostic models for distinguishing between limb-girdle muscular dystrophy and idiopathic inflammatory myopathy
by: Guangyu Wang, et al.
Published: (2024-12-01)

Retinal changes in patients with idiopathic inflammatory myopathies: A case-control study in the MyoCite cohort
by: Rachna Aggarwal, et al.
Published: (2022-11-01)

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry
by: Tatiana Cobo-Ibáñez, et al.
Published: (2025-01-01)

Idiopathic inflammatory myopathy and non-coding RNA
by: Yang Yang, et al.
Published: (2023-09-01)

Predictive model of diabetes mellitus in patients with idiopathic inflammatory myopathies
by: Qiong Nie, et al.
Published: (2023-04-01)

Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study
by: Brunetta Porcelli, et al.
Published: (2023-07-01)

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review
by: Julie J. Paik, et al.
Published: (2025-01-01)

Murine models of idiopathic inflammatory myopathy
by: Risa Konishi, et al.
Published: (2023-01-01)